Maravai Lifesciences Holdings (MRVI) Change in Cash (2020 - 2026)

Maravai Lifesciences Holdings' Change in Cash history runs 7 years deep, the most recent figure standing at -$51.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 36.48% year-over-year to -$51.0 million; the TTM figure through Mar 2026 stood at -$119.1 million (up 56.94% YoY), while the FY2025 annual figure was -$105.5 million, up 58.22% from the prior year.
• Change in Cash for Q1 2026 stood at -$51.0 million, down from -$26.7 million in the prior quarter.
• The five-year high for Change in Cash was $119.2 million in Q2 2022, with the low at -$255.8 million in Q4 2024.
• The 5-year median for Change in Cash is -$13.3 million (2024), against an average of -$22.7 million.
• Peak annual rise in Change in Cash reached 973.2% in 2024, while the deepest fall reached 5408.46% in 2024.
• Maravai Lifesciences Holdings' Change in Cash stood at $14.7 million in 2022, then tumbled by 131.6% to -$4.6 million in 2023, then tumbled by 5408.46% to -$255.8 million in 2024, then jumped by 89.57% to -$26.7 million in 2025, then sank by 91.01% to -$51.0 million in 2026.
• Business Quant data shows MRVI's Change in Cash at -$51.0 million in Q1 2026, -$26.7 million in Q4 2025, and -$26.3 million in Q3 2025.